KM Pharmaceutical EGM Passes Charter and Compensation Amendments... Low Turnout and Related-Party Loan Risk Highlighted

KM Pharmaceutical held an extraordinary general meeting on June 23, 2026, passing all three agenda items: amendment of articles of incorporation, establishment of executive compensation regulations, and revision of executive severance pay regulations.
Although approval rates were high at 99.5% to 100%, shareholder turnout was only 37.9% of total voting shares, indicating low minority shareholder participation.
These agenda items are procedural in nature and have limited direct impact on short-term shareholder value.
However, a related-party loan to Seokjeong Golf & Resort, a major shareholder affiliate, amounts to 10.4 billion KRW, approximately 90% of the company's market cap of 101.7 billion KRW, posing a significant financial burden.
[AI Summary]The EGM aimed to stabilize management through charter and compensation rule amendments, but the low turnout and excessive related-party loan risk highlight governance issues that could undermine investor confidence.